演題抄録

FACO Symposium

開催概要
開催回
第51回・2013年・京都
 

Dawn of the Asian Pediatric Hematology & Oncology Group (APHOG)

演題番号 : FS-4

[筆頭演者]
Akira Nakagawara:1,2 

1:President, Chiba Cancer Center, Chiba, Japan、2:Chairman, Asian Pediatric Hematology & Oncology Group (APHOG)

 

Asia is a huge continent occupying almost a half of the world population. However, the history, tradition, economic status, religion and policy of each Asian country are highly heterogeneous and different. In many developing (low- and middle-income, or resource-limited) countries in Asia, the important issues to be solved in children like education and health care have often been ignored. Especially, the sick children are very difficult to receive correct diagnosis and enough therapies. One of such serious diseases in children in the developing countries is cancer.
The epidemiological information about the cancers in developing countries is very poor. According to the so far available data, the mortality rates of the children with cancer in Asian developing countries appear to be very high (nearly 80~90%), while those in the developed countries even in Asia like Japan and Korea have already decreased to approximately 20~30%. Since the majority of Asian countries are under development, the average mortality rate of the patients with cancer is still very low.
To solve this serious problem in Asia, the leaders of Asian pediatric hematology and oncology from 13 countries gathered in Yogyakarta, Indonesia, in April, 1012, and had a kick-off meeting for founding the Asian Pediatric Hematology & Oncology Group (APHOG). Since then, we have made the by-laws and are constructing its structure including the core facilities, committees, tumor banks, pathological and molecular diagnostics, data center, database and follow-up systems. We are also planning to start the collaborative genomic analyses of pediatric cancers in Asia. We may first focus on pediatric leukemia and neuroblastoma and then expand to other solid tumors in children. Some clinical study protocols have already been proposed.
APHOG is closely collaborate with the International Society of Pediatric Oncology (SIOP), especially the SIOP-Asia. In addition, it is very important to collaborate with the clinical study groups of adult cancers that include FACO.

前へ戻る